1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Meningococcal Group C-CRM197 conjugate vaccine
Trade Name:
Menjugate
Manufacturer/Distributor:
Novartis
www.novartis.ca, 1-800-363-8883
e-mail: medinfo.canada@novartis.com
Classification:
Vaccine
ATC Class:
J07AH - meningococcal vaccines
Status:
active
Date Marketed in Canada (yyyy/mm/dd):
2009-01-30
Presentation:
0.5 mL powder for suspension
Comments:
Novartis has just started distribution of the vaccine (previously done by Merck Frosst). Indicated for active immunization of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.
